Back to Newsroom

Sucampo Names Peter Greenleaf Chief Executive Officer

BETHESDA, Md., February 10, 2014 – Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (“Sucampo”) today announced that Peter Greenleaf will join Sucampo as Chief Executive Officer (“CEO”) and as a member of the Board of Directors (“Board”) on March 3, 2014. Mr. Greenleaf, 43, brings to Sucampo more than 20 years of experience in commercialization and drug development in the biopharmaceutical industry.